Oncolytics Biotech Stock Price on December 12, 2024
| ONC Stock | CAD 1.20 0.02 1.64% |
Below is the normalized historical share price chart for Oncolytics Biotech extending back to November 08, 1999. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Oncolytics Biotech stands at 1.20, as last reported on the 13th of December 2024, with the highest price reaching 1.23 and the lowest price hitting 1.18 during the day.
If you're considering investing in Oncolytics Stock, it is important to understand the factors that can impact its price. As of now, Oncolytics Stock is extremely dangerous. Oncolytics Biotech maintains Sharpe Ratio (i.e., Efficiency) of 0.0043, which implies the firm had a 0.0043% return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Oncolytics Biotech, which you can use to evaluate the volatility of the company. Please check Oncolytics Biotech's Coefficient Of Variation of (359,611), variance of 26.59, and Risk Adjusted Performance of 0.0084 to confirm if the risk estimate we provide is consistent with the expected return of 0.0228%.
At this time, Oncolytics Biotech's Common Stock Shares Outstanding is very stable compared to the past year. As of the 13th of December 2024, Other Stockholder Equity is likely to grow to about 42.9 M, while Total Stockholder Equity is likely to drop about 17.8 M. . At this time, Oncolytics Biotech's Price Book Value Ratio is very stable compared to the past year. As of the 13th of December 2024, Price Earnings To Growth Ratio is likely to grow to 0.96, while Price To Sales Ratio is likely to drop 66.83. Oncolytics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 1.4357 | 50 Day MA 1.5076 | Beta 1.506 |
Oncolytics |
Sharpe Ratio = 0.0043
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ONC |
Estimated Market Risk
| 5.27 actual daily | 46 54% of assets are more volatile |
Expected Return
| 0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Oncolytics Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oncolytics Biotech by adding Oncolytics Biotech to a well-diversified portfolio.
Price Book 10.3821 | Book Value 0.37 | Enterprise Value 75.5 M | Enterprise Value Ebitda (2.45) | Shares Float 73.8 M |
Related Headline
JPMorgan Chase Headline on 12th of December 2024
JPMorgan Chases SWOT analysis stock outlook amid strong perf... by news.google.com
JPMorgan Chases SWOT analysis stock outlook amid strong performance, challenges Investing.com
Oncolytics Biotech Valuation on December 12, 2024
It is possible to determine the worth of Oncolytics Biotech on a given historical date. On December 12, 2024 Oncolytics was worth 1.21 at the beginning of the trading date compared to the closed value of 1.2. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Oncolytics Biotech stock. Still, in general, we apply an absolute valuation method to find Oncolytics Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oncolytics Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Oncolytics Biotech's related companies.
| Open | High | Low | Close | Volume | |
| 1.26 | 1.26 | 1.19 | 1.22 | 130,021 | |
12/12/2024 | 1.21 | 1.23 | 1.18 | 1.20 | 123,141 |
| Backtest Oncolytics Biotech | | | Oncolytics Biotech History | | | Oncolytics Biotech Valuation | Previous |
Oncolytics Biotech Trading Date Momentum on December 12, 2024
| On December 12 2024 Oncolytics Biotech was traded for 1.20 at the closing time. The maximum traded price for the trading interval was 1.23 and the lowest daily price was 1.18 . The daily volume was recorded at 123.1 K. The volume of trading on 12th of December 2024 did not cause price change. The trading delta at closing time to the closing price today is 0.83% . |
Oncolytics Biotech Fundamentals Correlations and Trends
By evaluating Oncolytics Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Oncolytics Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Oncolytics financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Oncolytics Biotech Stock history
Oncolytics Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oncolytics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oncolytics Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oncolytics Biotech stock prices may prove useful in developing a viable investing in Oncolytics Biotech
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 67.6 M | 71 M | |
| Net Loss | -22.4 M | -23.5 M |
Oncolytics Biotech Quarterly Net Working Capital |
|
Oncolytics Biotech Stock Technical Analysis
Oncolytics Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Oncolytics Biotech Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
Oncolytics Biotech cannot be verified against its exchange. Please verify the symbol is currently traded on Toronto Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Oncolytics Biotech December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how Oncolytics Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncolytics Biotech shares will generate the highest return on investment. By undertsting and applying Oncolytics Biotech stock market strength indicators, traders can identify Oncolytics Biotech entry and exit signals to maximize returns
Oncolytics Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Oncolytics Biotech's price direction in advance. Along with the technical and fundamental analysis of Oncolytics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Oncolytics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0084 | |||
| Jensen Alpha | 0.0908 | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | 0.0114 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncolytics Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Oncolytics Stock, please use our How to Invest in Oncolytics Biotech guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.